Name: Regeneron Pharmaceuticals, Inc. (REGN) Balance Sheet
Creator: FinSpry

Regeneron Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Regeneron Pharmaceuticals, Inc. (REGN) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	3.12	2.49	10.84	7.74	2.89	2.19	3.21	2.81
Short-Term Investments	5.49	6.52	8.11	4.64	2.81	1.39	0.00	0.00
Cash & Short-Term Investments	8.61	9.01	10.84	7.74	5.69	3.59	3.21	2.81
Accounts Receivable	5.74	6.21	5.67	5.33	6.04	4.11	2.10	2.24
Inventory	3.20	3.09	2.58	2.40	1.95	1.92	1.42	1.15
Other Current Assets	0.47	0.35	0.70	0.54	0.33	0.16	0.21	0.00
Total Current Assets	18.02	18.66	19.48	15.88	14.01	9.78	7.00	6.45
Non-Current Assets
Property, Plant & Equipment (Net)	5.12	4.60	4.15	3.76	3.48	3.22	2.89	2.58
Long-Term Investments	10.59	8.90	5.47	6.64	6.88	3.19	0.00	0.00
Intangible Assets	1.26	1.15	1.04	0.92	0.01	0.00	0.00	0.00
Other Non-Current Assets	1.82	1.14	0.44	0.34	0.22	0.11	0.14	0.13
Total Non-Current Assets	22.54	19.10	13.60	13.33	11.42	7.38	7.12	5.29
Total Assets	40.56	37.76	33.08	29.21	25.43	17.16	14.12	11.73
Current Liabilities
Accounts Payable	0.94	0.79	2.96	2.66	0.56	0.48	1.63	0.99
Accrued Liabilities	2.53	2.31	2.34	2.07	1.59	1.61	0.00	0.00
Deferred Revenue	0.55	0.63	0.46	0.48	0.44	0.58	0.00	0.00
Other Current Liabilities	2.88	2.31	0.62	0.50	0.44	0.02	0.09	0.00
Total Current Liabilities	4.37	3.94	3.42	3.14	3.93	2.70	1.71	1.44
Non-Current Liabilities
Long-Term Debt	1.99	1.98	2.70	2.70	1.98	1.98	0.71	0.71
Other Non-Current Liabilities	2.02	1.57	0.85	0.64	0.68	0.69	0.10	0.36
Total Non-Current Liabilities	4.93	4.46	3.68	3.41	2.73	3.44	0.71	1.53
Total Liabilities	9.30	8.41	7.11	6.55	6.67	6.14	2.43	2.98
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	35.80	31.67	27.18	23.07	18.97	10.89	7.40	5.25
Accumulated Other Comprehensive Income	0.08	-0.01	-0.08	-0.24	-0.03	0.03	0.02	-0.01
Treasury Stock	18.61	15.17	-12.56	-10.35	8.26	-6.61	-0.74	-0.40
Additional Paid-in Capital	14.00	12.86	11.35	9.95	8.09	6.72	4.43	3.91
Shares Outstanding	0.11	0.11	0.11	0.11	0.11	0.00	0.00	0.00
Total Stockholders' Equity	31.26	29.35	25.97	22.66	18.77	11.03	11.09	8.76
Total Liabilities & Equity	40.56	37.76	33.08	29.21	25.43	17.16	14.12	11.73